Search - tctmd.com

Displaying 1 - 20 of 101

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1519: Jailed, but Unharmed: Navigating Bi-Caval TricValve Implantation in Tricuspid Regurgitation With Multiple Pre-Existing Leads: A Complex Case From the TRICAV I US Early Feasibility Study

Presenter: Brian K. Whisenant

October 28, 2025

Presentation TCT 2025

Interventionalist's Viewpoint

Presenter: Brian K. Whisenant

October 28, 2025

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

Presentation TCT 2023

LVOT Management

Presenter: Brian Whisenant

October 25, 2023

Presentation TCT 2022

MAC and Small Valve Areas

Presenter: Brian K. Whisenant

September 19, 2022

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Case #1

Presenter: Brian K. Whisenant

September 17, 2022

Presentation TCT 2022

Valve in Bioprosthetic Mitral Failure: Technical Considerations, Outcomes, and Complications

Presenter: Brian Whisenant

September 17, 2022

Presentation TCT 2021

Closing Complex Anatomies LAAO Devices

Presenter: Brian Whisenant

November 06, 2021

Presentation TCT 2021

Reconciling Anatomical Indications With TMVR Technical Advantages and Limitations

Presenter: Brian Whisenant

November 05, 2021

Presentation TCT 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presenter: Brian Whisenant

September 28, 2019

Presentation TCT 2019

Direct Annuloplasty: Cardioband and Millipede — Device Description, Results, and Ongoing Studies

Presenter: Brian Whisenant

September 27, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

Unmet Clinical Needs and Future Directions

Presenter: Brian Whisenant

September 25, 2019

Presentation TCT 2018

LAA Closure: Challenging Case Vignettes

Presenter: Saibal Kar, Horst Sievert, Philippe Garot, Jan Kovac, Ashish Pershad, Ramon Quesada, Peter B. Sick, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

The WaveCrest Device and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

The Amulet Platform, Experience and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Apostolos Tzikas

September 24, 2018

Presentation TCT 2018

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

Presenter: Vivek Y. Reddy, Brian K. Whisenant

September 24, 2018

Advertisement

TCT 1519: Jailed, but Unharmed: Navigating Bi-Caval TricValve Implantation in Tricuspid Regurgitation With Multiple Pre-Existing Leads: A Complex Case From the TRICAV I US Early Feasibility Study

Interventionalist's Viewpoint

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

LVOT Management

MAC and Small Valve Areas

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Case #1

Valve in Bioprosthetic Mitral Failure: Technical Considerations, Outcomes, and Complications

Closing Complex Anatomies LAAO Devices

Reconciling Anatomical Indications With TMVR Technical Advantages and Limitations

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Direct Annuloplasty: Cardioband and Millipede — Device Description, Results, and Ongoing Studies

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Unmet Clinical Needs and Future Directions

LAA Closure: Challenging Case Vignettes

The Watch TAVR Trial: Rationale, Design and Status

The WaveCrest Device and US Pivotal Trial

The Amulet Platform, Experience and US Pivotal Trial

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content